Correlation Between Gamida Cell and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Gamida Cell and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gamida Cell and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gamida Cell and Effector Therapeutics, you can compare the effects of market volatilities on Gamida Cell and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gamida Cell with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gamida Cell and Effector Therapeutics.
Diversification Opportunities for Gamida Cell and Effector Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Gamida and Effector is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gamida Cell and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Gamida Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gamida Cell are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Gamida Cell i.e., Gamida Cell and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Gamida Cell and Effector Therapeutics
If you would invest (100.00) in Effector Therapeutics on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Effector Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Gamida Cell vs. Effector Therapeutics
Performance |
Timeline |
Gamida Cell |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Effector Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Gamida Cell and Effector Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gamida Cell and Effector Therapeutics
The main advantage of trading using opposite Gamida Cell and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gamida Cell position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.Gamida Cell vs. BioLineRx | Gamida Cell vs. Ardelyx | Gamida Cell vs. Lexicon Pharmaceuticals | Gamida Cell vs. Seres Therapeutics |
Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |